Abstract
Telomerase expression is a potentially important marker of high-grade cervical dysplasia and squamous cell carcinoma (SCC). The routine practice of cervical cytology is limited by problems of false negative diagnoses as well as by poor specificity for clinically significant lesions in patients with low-grade cytologic abnormalities. Telomerase is widely expressed in most SCCs as well as in a high proportion of high-grade squamous intraepithelial lesions. Histochemical studies have confirmed that telomerase is expressed in the lower portions of normal or metaplastic squamous mucosa but that telomerase positive cells extend into the upper epithelial layers in cases of high-grade dysplasia. Since the cervical smear samples the uppermost cell layers of the cervical mucosa, but does not normally include cells derived from the lower layers of the squamous mucosa, the detection of telomerase in exfoliated cells of the cervical smear may have specificity for clinically significant lesions. The analysis of hTR, hTERT, and telomerase activity are complicated by a number of technical factors that may lead to either false negative or false positive test results. Thus, the practical application of telomerase analysis as a diagnostic adjunct for cervical cytopathology may depend on the development of more reliable and sensitive assay systems, possibly formatted for cytochemical applications.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson S, Shera K, Ihle J, Billman L, Goff B, Greer B, Tamimi H, McDougall J, Klingelhutz A . 1997 Am. J. Pathol. 151: 25–31
Benoit AG, Krepart GV, Lotocki RJ . 1984 Am. J. Obstet. Gynecol. 148: 690–694
Berkeley AS, LiVolsi VA, Schwartz PE . 1980 Lancet ii: 375–376
Birley HD . 1995 Ann. Trop. Med. Parasit. 89: 453–463
Brien TP, Kallakury BVS, Lowry CV, Ambros RA, Muraca PJ, Malfetano JH, Ross JS . 1997 Cancer Res. 57: 2760–2764
Cancer Facts & Figures. 2001 American Cancer Society, Atlanta, GA
Chang Chien CC, Lin H, Leung SW, Hsu CY, Cho CL . 1998 Gynecol. Oncol. 71: 99–103
Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR . 2000 Neoplasia 2: 426–432
DeMay RM . 1996a Am. J. Obstet. Gynecol. 175: 1110–1113
DeMay RM . 1996b Exfoliative cytology Chicago: ASCP Press pp 61–205
Enomoto T, Haba T, Fujita M, Hamada T, Yoshino K, Nakashima R, Wada H, Kurachi H, Wakasa K, Sakarai M, Murata Y, Shroyer KR . 1997 Int. J. Cancer 73: 1–6
Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW, Villeponteau B . 1995 Science 269: 1236–1241
Frost M, Bobak J, Gianani R, Kim N, Weinrich S, Spaulding DC, Cass LG, Thompson LC, Enomoto T, Lopez-Uribe D, Shroyer KR . 2000 Am. J. Clin. Path. 114: 726–734
Gay JO, Donaldson LD, Goellner JR . 1985 Acta Cytol. 28: 1043–1046
Gorham H, Yoshida K, Sugino T, Marsh G, Manek S, Charnock M, Tarin D, Goodison S . 1997 J. Clin. Pathol. 50: 501–504
Guidozzi F . 1996 Obstet. Gynecol. Sur. 51: 247–252
Gullu IH, Kurdoglu M . 1999 Br. J. Cancer 81: 186–
Hatch KD, Schneider A, Abdel-Noar MW . 1995 Am. J. Obstet. Gynecol. 172: 1150–1157
Hiyama E, Hiyama K, Yokoyama T, Shay JW . 2001 Neoplasia 3: 17–26
Iwasaka T, Zheng PS, Yokoyama M, Fukuda K, Nakao Y, Sugimori H . 1998 Obstet. Gynecol. 91: 260–262
Kawai K, Yaginuma Y, Tsuruoaka H, Griffin M, Hayashi H, Ishikawa M . 1998 Eur. J. Cancer 34: 2082–2086
Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA . 1997 Hum. Mol. Genet. 6: 2011–2019
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW . 1994 Science 266: 2011–2015
Klingelhutz AJ, Foster AJ, McDougall JK . 1996 Nature 380: 79–82
Krieger P, Naryshkin S . 1994 Acta Cytol. 38: 291–298
Kurman RJ, Solomon D . 1994 The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses New York: Springer-Verlag pp 9–80
Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M . 1996 Clin. Cancer Res. 2: 2023–2028
Kyo S, Takakura M, Kohama T, Inoue M . 1997 Cancer Res. 57: 610–614
Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M . 1998 Int J Cancer 79: 66–70
Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA . 1999 JAMA 281: 1605–1610
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beyersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA . 1997 Cell 90: 785–795
Mutirangura A, Sriuranpong V, Termrunggraunglert W, Tresukosol D, Lertsaguansinchai P, Voravud N, Niruthisard S . 1998 Br. J. Cancer 78: 933–939
Nagai N, Oshita T, Murakami J, Ohama K . 1999 Oncol. Rep. 6: 325–328
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Linger J, Harley CB, Cech TR . 1997 Science 277: 955–959
Nakano K, Watney E, McDougal JK . 1998 Am. J. Pathol. 153: 857–864
Naryshkin S . 1997 Arch. Pathol. Lab. Med. 121: 270–272
Oh ST, Kyo S, Laimins LA . 2001 J. Virol. 75: 5559–5566
Pairwuti S . 1991 Acta Cytol. 35: 40–46
Pao CC, Tseng CJ, Lin CY, Yang FP, Hor JJ, Yao DS, Hsueh S . 1997 J. Clin. Oncol. 15: 1932–1937
Park T-W, Fujiwara H, Wright TC . 1995 Cancer Suppl. 76: 1902–1913
Park TW, Richart RM, Sun X W, Wright Jr TC . 1996 J. Natl. Cancer Inst. 88: 355–358
Reddy VG, Khanna N, Jain SK, Das BC, Singh N . 2001 Int. J. Cancer 11: 100–106
Richart RM . 1993 Pathol Ann. 8: 301–328
Riethdorf S, Riethdorf L, Schulz G, Ikenberg H, Janicke F, Loning T, Park TW . 2001 Int. J. Gynecol. 20: 177–185
Robertson JH, Woodend B . 1993 J. Clin. Pathol. 46: 700–702
Shay JW, Zou Y, Hiyama E, Wright WE . 2001 Hum. Mol. Genet. 10: 677–685
Shroyer KR, Stephens JK, Silverberg SG, Markham N, Shroyer AL, Wilson ML, Enomoto T . 1997 Int. J. Gynecol. Pathol. 16: 225–232
Shroyer KR, Thompson C, Enomoto T, Eskens J, Shroyer AL, McGregor JA . 1998 Am. J. Clin. Pathol. 109: 153–162
Snijders PJ, van Duin M, Walboomers JM, Steenbergen RD, Risse EK, Helmhorst TJ, Verheijen RH, Meijer CJ . 1998 Cancer Res. 58: 3812–3818
Solomon D, Schiffman M, Tarone R, for the ALTS Group . 2001 J. Natl. Cancer Inst. 93: 293–299
Stoppler H, Hartman DP, Sherman L, Schlegel R . 1997 J. Biol. Chem. 272: 13332–13337
Tabbara SO, Sidawy MK . 1996 Diagn. Cytopathol. 14: 84–86
Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M . 1998 Cancer Res. 58: 1558–1561
Tkeshelashvili VT, Bokhan JV, Kuznetzov VV, Maximov SJ, Chkuaseli GT . 1993 Eur. J. Gynaec. Onc. 14: 89–94
Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR . 1998 Cancer Res. 58: 4168–4172
van der Graaf Y, Vooijs GP . 1987 J. Clin. Pathol. 40: 438–442
van der Graaf Y, Vooijs GP, Gaillard HLJ, Go DM . 1987 Acta Cytol. 31: 434–438
Wick M, Zubov D, Hagen G . 1999 Gene 17: 97–106
Wisman GB, Hollema H, de Jong S, ter Scheggert J, Tjong-Hung SP, Ruiters MH, Krans M, de Vries EG, van der Zee AG . 1998 J. Clin. Oncol. 16: 2238–2245
Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries EG, Keith WN, van der Zee AG . 2000 Hum. Pathol. 31: 1304–1312
Wisman GB, Knol AJ, Helder MN, Krans M, de Vries EG, Hollema H, de Jong S, van der Zee AG . 2001 Int. J. Cancer 91: 658–664
Wolf JK, Ramirez PT . 2001 Cancer Invest. 19: 621–629
Wright TC, Kurman RJ, Ferenczy A . 1994a Blaustein's Pathology of the Female Genital Tract 4th edn Kurman RJ. (ed) New York: Springer-Verlag pp 287–289
Wright TC, Kurman RJ, Ferenczy A . 1994b Blaustein's Pathology of the Female Genital Tract 4th edn Kurman RJ. (ed) New York: Springer-Verlag pp 229–232
Wright TC, Sun XW, Koulos J . 1995a Obstet. Gynecol. 85: 202–210
Wright WE, Shay JW, Piatyszek MA . 1995b Nucl. Acids Res. 23: 3794–3795
Wu Y-Y, Hruszkewycz AM, Delgado RM, Yang A, Vortmeyer AO, Moon Y-W, Weil RJ, Zhuang Z, Remaley AT . 2000 Clin. Chim. Acta 293: 199–212
Yahata N, Nagao K, Ohyashiki JH, Hisatomi H, Ohyashiki K . 1999 Int. J. Oncol. 14: 709–712
Yashima K, Ashfaq R, Nowak J, Von Gruenigen V, Milchgrub S, Rathi A, Albores-Saavedra J, Shay JW, Gazdar AF . 1998 Cancer 82: 1319–1327
Yi X, White DM, Aisner DL, Baur JA, Wright WE, Shay JW . 2000 Neoplasia 2: 433–440
Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Tamaya T . 1998 Gynecol. Oncol. 68: 145–149
Zhang DK, Ngan HY, Cheng AN, Cheung AN, Liu SS, Tsao SW . 1999 Eur. J. Cancer 35: 154–160
Zheng P-S, Iwasaka T, Yokoyama M, Nakao Y, Pater A, Sugimori H . 1997 Gynecol. Oncol. 66: 222–226
zur Hausen H . 1996 Biochim. Biophys. Acta 1288: F55–F78
zur Hausen H . 1999 Proc. Assoc. Am. Physic. 111: 581–587
Acknowledgements
Research related to this review was supported in part by grant R01 CA78442-01A1 from the National Cancer Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jarboe, E., Liaw, KL., Thompson, L. et al. Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 21, 664–673 (2002). https://doi.org/10.1038/sj.onc.1205073
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205073
Keywords
This article is cited by
-
Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer
Scientific Reports (2017)
-
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
Cancer Microenvironment (2011)
-
Immunohistochemical expression of ubiquitin and telomerase in cervical cancer
Virchows Archiv (2009)
-
Früherkennung des Zervixkarzinoms
Der Onkologe (2008)
-
Sekundäre Prävention des Zervixkarzinoms: aktueller Stand der Diagnostik
Der Gynäkologe (2007)